Looking for Adalimumab found 22 matches
|
| Open monograph to display formulary status |
BNF Category |
| |
Adalimumab
(Gastroenterology)
|
Gastro-intestinal system - Cytokine inhibitors : Treatment of ulcerative colitis and Crohn’s disease - 01.05.03
|
| |
Adalimumab
(rheumatology)
|
Musculoskeletal and joint diseases - Drugs affecting the immune response - 10.01.03
|
| |
Adalimumab
(Dermatology)
|
Skin - Cytokine modulators (biologic therapies) - psoriasis - 13.05.03.02
|
| |
Links Link to Drug Section  Link to document |
|
NICE TA146: Adalimumab for the treatment of adults with psoriasis (13.05.03.02)
|
|
NICE TA187: Crohn’s disease - infliximab and adalimumab (01.05.03)
|
|
NICE TA187: Crohns disease - infliximab & adalimumab (01.05.03)
|
|
NICE TA195: Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor (10.01.03)
|
|
NICE TA199: Psoriatic arthritis - etanercept, infliximab and adalimumab (10.01.03)
|
|
NICE TA329: Infliximab, adalimumab and golimumab for moderately to severely active ulcerative colitis (01.05.03)
|
|
NICE TA329: Infliximab, adalimumab and golimumab for moderately to severely active ulcerative colitis (01.05.03)
|
|
NICE TA329: Infliximab, adalimumab and golimumab for moderately to severely active ulcerative colitis (01.05.03)
|
|
NICE TA373: Abatacept, adalimumab, etanercept and tocilizumab for JIA (10.01.03)
|
|
NICE TA373: Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis (10.01.03)
|
|
NICE TA373: Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis (10.01.03)
|
|
NICE TA373: Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis (10.01.03)
|
|
NICE TA375: Rheumatoid arthritis - Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept (10.01.03)
|
|
NICE TA392: Adalimumab for treating moderate to severe hidradenitis suppurativa (13.05.03.02)
|
|
NICE TA455 : Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young peopl (10.01.03)
|
|
NICE TA455 : Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young peopl (13.05.03.02)
|
|
NICE TA455 : Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people (10.01.03)
|
|
NICE TA460 : Adalimumab and dexamethasone for treating non-infectious uveitis (01.05.03)
|
|
NICE TA460 : Adalimumab and dexamethasone for treating non-infectious uveitis (10.01.03)
|
|
|
